137 related articles for article (PubMed ID: 10352502)
1. [Diagnostic importance of fibronectin in chronic liver diseases].
Golubović M; Majkić-Singh N; Marković S; Sumarac Z; Obradović I
Med Pregl; 1999; 52(1-2):35-8. PubMed ID: 10352502
[TBL] [Abstract][Full Text] [Related]
2. [Plasma fibronectin in chronic liver disease--marker of fibrosis?].
Simon K; Zalewska M; Gładysz A; Rotter K; Piszko P; Głowacki A
Przegl Lek; 1995; 52(4):129-32. PubMed ID: 7638358
[TBL] [Abstract][Full Text] [Related]
3. [Plasma fibronectin in chronic liver diseases].
Soresi M; Di Martino D; Montalto G; Carroccio A; Ruggeri MI; Bascone F; Ippolito S; Notarbartolo A
Recenti Prog Med; 1993 Sep; 84(9):602-7. PubMed ID: 8210624
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of fibronectin in patients with chronic viral and alcoholic liver disease.
Grieco A; Matera A; Di Rocco P; Marcoccia S; Giancaterini A; Alfei B; Addolorato G; Varlese F; Gasbarrini G
Hepatogastroenterology; 1998; 45(23):1731-6. PubMed ID: 9840137
[TBL] [Abstract][Full Text] [Related]
5. The use of tissue polypeptide specific antigen as a marker in liver diseases.
Cetin T; Oğuz A; Algan P; Yildirim IS
Turk J Gastroenterol; 2003 Sep; 14(3):177-80. PubMed ID: 14655061
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin, cholesterol and triglycerides ascitic fluid concentration in the prediction of malignancy.
Colloredo Mels G; Bellati G; Auriemma L; Perani C; Leandro G; Vacca N; Pinna N; Alfieri G; Ideo G
Ital J Gastroenterol; 1991 May; 23(4):179-86. PubMed ID: 1661195
[TBL] [Abstract][Full Text] [Related]
7. [Determination of plasma fibronectin (Fn) levels. Comparison between normal subjects and patients with various pathological conditions].
Gironi A; Niccolai J; Fabbri LP; Niccolai M; Chisci C
Quad Sclavo Diagn; 1982 Dec; 18(4):392-405. PubMed ID: 6764670
[TBL] [Abstract][Full Text] [Related]
8. [Tumor markers in focal and diffuse liver diseases].
Kasatkin IuN; Ametov AS; Mit'kov VV; Sevast'ianov SI; Zarudin VV
Med Radiol (Mosk); 1984 Apr; 29(4):39-43. PubMed ID: 6201693
[TBL] [Abstract][Full Text] [Related]
9. Sequential changes in plasma cytokine and endotoxin levels in cirrhotic patients with bacterial infection.
Wang SS; Lee FY; Chan CC; Lu RH; Chao Y; Lin HC; Wu SL; Tsai YT; Lee SD
Clin Sci (Lond); 2000 Apr; 98(4):419-25. PubMed ID: 10731475
[TBL] [Abstract][Full Text] [Related]
10. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.
Marrero JA; Su GL; Wei W; Emick D; Conjeevaram HS; Fontana RJ; Lok AS
Hepatology; 2003 May; 37(5):1114-21. PubMed ID: 12717392
[TBL] [Abstract][Full Text] [Related]
11. [Clinical usefulness of plasma activities of gelatinase (matrix metalloproteinase-2 and 9) in chronic liver disease].
Kwon OS; Lim DY; Kwon KA; Chung MG; Park DK; Kim SS; Kim YS; Kwon SY; Koo YS; Kim YK; Choi DJ; Kim JH; Hwang YJ; Byun KS; Lee CH
Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):222-30. PubMed ID: 14515040
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of plasma fibronectin level in predicting the presence and severity of coronary artery disease.
Ozcelik F; Erdogan O; Aktoz M; Ekuklu G; Tatli E; Demir M
Ann Hematol; 2009 Mar; 88(3):249-53. PubMed ID: 18716775
[TBL] [Abstract][Full Text] [Related]
13. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract][Full Text] [Related]
14. Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites.
Alam I; Bass NM; Bacchetti P; Gee L; Rockey DC
Am J Gastroenterol; 2000 Jan; 95(1):199-203. PubMed ID: 10638583
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of serum percent trisialotransferrin as potential predictive biomarker of hepatocellular dedifferentiation in chronic liver disease.
Gressner OA; Jafari S; Erkens M; Gao C; Stanzel S; Gressner AM
Clin Chim Acta; 2009 May; 403(1-2):188-93. PubMed ID: 19281805
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease.
Naveau S; Gaudé G; Asnacios A; Agostini H; Abella A; Barri-Ova N; Dauvois B; Prévot S; Ngo Y; Munteanu M; Balian A; Njiké-Nakseu M; Perlemuter G; Poynard T
Hepatology; 2009 Jan; 49(1):97-105. PubMed ID: 19053048
[TBL] [Abstract][Full Text] [Related]
17. Changes of plasma D(-)-lactate, diamine oxidase and endotoxin in patients with liver cirrhosis.
Ruan P; Gong ZJ; Zhang QR
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):58-61. PubMed ID: 14969839
[TBL] [Abstract][Full Text] [Related]
18. [Plasma fibronectin and alcoholic liver disease].
Ricciardi R; Restuccia G; Chindemi G
Quad Sclavo Diagn; 1987 Jun; 23(2):153-63. PubMed ID: 3451292
[TBL] [Abstract][Full Text] [Related]
19. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection.
Zhao L; Li T; Wang Y; Pan Y; Ning H; Hui X; Xie H; Wang J; Han Y; Liu Z; Fan D
Int J Clin Pract; 2008 Jul; 62(7):1056-62. PubMed ID: 17537188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
